Metlifecare Limited — Annual Report 2025 (year ended 30 June)
Metlifecare Limited
Provider claim
Community provider
2026-10-10
Next review: 2027-04-10
New Zealand operator portfolio; company-specific coverage and reporting period
Medium confidence
verified
Primary-source research review
Evidence boundary: Commercial issuer primary evidence for the year ended 30 June 2025; all 76 physical pages inspected. Publication on 29 August is distinct from 28 August signatures/production. Profile figures exclude the 50%-owned Palmerston North joint venture, although the directory also lists that village and the financial statements equity-account for it. Completed units and care suites, planned landbank, bureau shift requests and employee survey participation have different denominators. Financial audit excludes wider care/workforce/climate narrative; separate climate/SLL assurance engagements were not fully reviewed here. Market-based, location-based and intensity emissions measures are not interchangeable. Future development, suite admission, technology, climate and Napier transaction plans are not confirmed outcomes. Historic ORA terms in financial notes do not establish universal current contract/legal rights. Original PDF/name/hash/category and June 2026 access history are preserved; current issuer-linked bytes verified 10 October 2026. FY2026 reports now exist. No current care-access guarantee, independent clinical-quality assessment or investment recommendation.
Short Answer
Historical FY2025 report covering village and co-located care capacity, mixed unit/suite completions, workforce feedback, development plans, emissions accounting and audited financial statements; portfolio excludes the Palmerston North joint venture.
Why it matters
Compare period-specific care integration, staffing feedback and development reporting; distinguish mixed units/suites, ORA cash flows, fair-value gains and emissions definitions before combining operator data.
Key Points
- •Reporting year ended 30 June 2025. Financial statements and audit are dated 28 August; the issuer archive and NZX announcement date publication to 29 August 2025. The retained PDF has 76 physical pages (pp. 2, 35, 69; issuer sources).
- •The 30 June 2025 profile reports 36 villages, 25 co-located care homes, 5,350 independent living units, 422 serviced apartments and 1,177 care beds/suites, excluding the 50% Palmerston North joint venture (p. 4).
- •The company reports 332 units and care suites completed across ten villages in FY2025; this mixed total is not 332 aged residential care beds (p. 12).
- •The landbank comprises 1,711 planned units and care suites across greenfield, regeneration and existing-village projects; it is not current operating capacity (pp. 4, 13).
- •The May 2025 employee survey had 74% participation and employee NPS +42; this describes employee feedback rather than resident satisfaction or nationwide workforce conditions (p. 21).
- •The company reports MetFlex filling 92% of requested shifts. The denominator is bureau requests, not all shifts, staffing ratios or clinical-safety outcomes (p. 23).
Full Summary & Notes
Historical FY2025 report covering village and co-located care capacity, mixed unit/suite completions, workforce feedback, development plans, emissions accounting and audited financial statements; portfolio excludes the Palmerston North joint venture.
Open the full summary for detailed notes and source links.
Metlifecare’s 76-page annual report covers the year ended 30 June 2025. Financial statements and the audit opinion were signed on 28 August 2025; the issuer archive and NZX announcement place publication on 29 August. The current issuer-linked PDF matches the original June 2026 capture byte for byte.
At 30 June the company profile reports 36 villages, 25 co-located care homes, 5,350 independent living units, 422 serviced apartments and 1,177 care beds and suites. Those profile figures exclude the 50%-owned Palmerston North joint venture. The 332 FY2025 completions combine retirement units and care suites across ten villages; the 1,711-unit/suite landbank is planned development rather than operating beds. The May 2025 employee survey reports 74% participation and employee NPS +42.
Audited net profit after tax was $66.394 million, including a $135.424 million investment-property fair-value gain. Gross ORA sales receipts of $546.428 million are not operating revenue or net care earnings. PwC’s unmodified opinion covers financial statements on pages 32–63; other annual-report information, including climate narrative, is outside that opinion. The reported 44% reduction in market-based Scope 1 and 2 emissions differs from location-based electricity emissions, which increased.
Use the report to understand historical care integration, staff feedback, capital/development reporting and emissions boundaries. Plans for FY2026, future suite admissions and the Napier land transaction require later evidence: the financial note describes an unconditional agreement in August 2025 with settlement expected by March 2027. This edition establishes neither current vacancies and contract terms nor delivery of those plans. FY2026 reports are now listed by the issuer.
Read bundled source notes
The saved source file may include fuller notes and references than the indexed summary. Check its dates and evidence limits.
Loading saved source notes…
Document Details & Metadata
Related Resources
Historical FY2024 operator report on care occupancy, resident and employee feedback, development, audited financial statements, climate scenarios and governance; underlying profit and care-quality narrative have separate assurance limits.
FY2024 care operator report on high-acuity beds, employee and resident feedback, RConnect staffing, community activity, new home-support plans and audited financial results; 49 PDF spreads contain the numbered report through page 95.
42-page FY2026 financial annual report with a short portfolio and leadership overview, audited statements, valuation and resident-loan notes, planned development and limited resident-feedback reporting; separate from the two-page results release.
Four-page May 2026 issuer release on reported care occupancy, adjusted earnings, planned Karori acquisition, new-build care projects and home-support expansion; forecast capacity and promotional service claims require separate verification.
The report brings together a corporate portfolio overview, strategy, resident experience, workforce and environmental initiatives, audited consolidated financial statements and remuneration/governance reporting. Its accounts report a statutory loss despite improved adjusted operating earnings and positive aggregate free cash flow; the existing-operations component of that cash flow remains negative. Restated FY25 values and the note 2 reconciliation are essential for comparisons. Use the company’s dated care occupancy and portfolio figures to frame questions, with mature-site and cross-country boundaries retained. Organisation-wide team members are not clinical staffing FTE; NPS and participation scores lack detailed survey denominators. Testimonials, product roll-outs and training claims are commercial narrative rather than independently evaluated clinical evidence. Future construction, demographic assertions and dividend/funding expectations require separate subsequent verification.
Report-based reconciliation of a June 2026 source brief. Original authored publication date is known only to year 2026; 5 June dates the annual report, not necessarily the brief. Detailed narrative retains historical strategy and June news context while correcting report contradictions; analyst reaction, subsequent bond events and later role/project outcomes are not independently checked in this scoped review.